|Videos|December 14, 2022
Interview with Syngene at CPHI in Frankfurt, Germany
Author(s)Syngene
KEY LEARNING OBJECTIVES
- Syngene is an end-to-end CRO/CDMO which offers standalone as well as integrated services for small molecules and biologics
- We not only have capabilities but also capacity to fulfil commercial manufacturing requirements
- We can be a innovation partner for niche areas as well as small biotech/pharma companies
Related Content
Trending on Pharmaceutical Technology
1
Technology Transfer: Success Drivers and Obstacles Explained
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5